AVNS logo

Avanos Medical (AVNS) Company Overview

Profile

Full Name:

Avanos Medical, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

October 21, 2014

Indexes:

Not included

Website:

http://avanos.com

Description:

Avanos Medical, Inc. offers a wide range of products focused on respiratory and digestive health; pain management solutions; as well as minimally invasive interventional methods for pain treatment, closed suction systems for airways, and enteral feeding tubes. The company also offers Game Ready products for pain relief and rehabilitation of patients recovering from orthopedic surgeries or sports injuries; GRPro 2.1 cold and compression therapy system; Med4Elite, a multimodal therapy block; ATX wraps; and various accessories for products. Additionally, it sells its products under the brands ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY. Avanos Medical, Inc. was registered in 2014 and is headquartered in Alpharetta, Georgia.

Key Details

Price

$15.88

Market Cap

$730.53 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$687.80 M(+2.15% YoY)

Annual EPS

-$8.53(-546.21% YoY)

PE Ratio

-

Annual ROE

-37.98%

Annual Debt To Equity

0.16

Beta

0.67

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

May 7, 24 JMP Securities
Market Perform
Jul 25, 23 Keybanc
Sector Weight
Jun 21, 23 Stifel
Hold
May 22, 23 CL King
Buy
May 4, 23 Morgan Stanley
Underweight
Feb 22, 23 Morgan Stanley
Underweight
Jan 6, 23 Morgan Stanley
Underweight
Nov 3, 22 Keybanc
Overweight
Oct 11, 22 Morgan Stanley
Underweight
Aug 10, 22 Keybanc
Overweight

Screeners with AVNS included

US stocks
High Piotroski score stocks
Stocks below SMA 200
Stocks recommended to hold
Stocks below analysts price target
Healthcare sector
All stocks
Companies with buyback
Small cap stocks
Medical Devices industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$15.88
AVNS price is $15.88

Price All-time High

$72.65
AVNS price is currently -78.14% below its historical high of $72.65

Price Analysts Target

$17.00
AVNS price is currently -6.59% lower than the consensus analysts' forecast

Price Most Recent Change

+4.82%
AVNS price was up +4.82% on Mar 3, 2025

Price YTD Change

-0.25%
AVNS price is down -0.25% since January 1st

Price 3-Year Change

-53.97%
AVNS price is down -53.97% over the past 3 years

Market cap

Market Cap

$730.53 M
AVNS market capitalization is $730.53 million

Market Cap 3-Year Change

-55.25%
AVNS market capitalization is down -55.25% over the past 3 years

Market Cap All-time High

$3.44 B
AVNS market capitalization is currently -78.73% below its historical high of $3.44 billion

Market Cap Sector Rank

72.26%
AVNS market capitalization is higher than 72.26% of companies in Healthcare sector

Technical

Beta

0.67
AVNS beta is 0.67

200-day SMA

$20.04
AVNS price is currently -20.75% below its 200-day simple moving average

14-day RSI

35.04
AVNS 14-day relative strength index is 35.04

30-day Relative Volume

1.14
AVNS 30-day relative volume is 1.14

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$687.80 M
AVNS annual revenue is $687.80 million

Annual Revenue Analysts Estimate

$673.50 M
AVNS annual revenue is currently +2.12% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+2.15%
AVNS annual revenue is up +2.15% year-on-year

Annual Revenue Sector Rank

76.88%
AVNS annual revenue is higher than 76.88% of companies in Healthcare sector

Profit

Annual Gross Profit

$381.30 M
AVNS annual gross profit is $381.30 million

Annual Gross Margin

55.44%
AVNS annual gross profit margin is 55.44%

Annual Operating Profit

$40.50 M
AVNS annual operating income is $40.50 million

Annual Operating Margin

5.89%
AVNS annual operating profit margin is 5.89%

Annual Net Income

-$392.10 M
AVNS annual net profit is -$392.10 million

Annual Net Margin

-57.01%
AVNS annual net profit margin is -57.01%

EPS

Annual EPS

-$8.53
AVNS annual earnings per share is -$8.53

Annual EPS Analysts Estimate

$1.13
AVNS annual earnings per share is currently -858.22% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-546.21%
AVNS annual earnings per share is down -546.21% year-on-year

Annual EPS Sector Rank

16.54%
AVNS annual earnings per share is higher than 16.54% of companies in Healthcare sector

ROA & ROE

Annual ROA

-27.55%
AVNS annual return on assets is -27.55%

Annual ROE

-37.98%
AVNS annual return on equity is -37.98%

EBIT & EBITDA

Annual EBIT

-$391.10 M
AVNS annual earnings before interest & taxes is -$391.10 million

Annual EBITDA

-$345.60 M
AVNS annual EBITDA is -$345.60 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
AVNS price to earnings ratio value is unknown

PE Ratio Sector Rank

-
AVNS price to earnings ratio is unknown

PB Ratio

PB Ratio

0.88
AVNS price to book ratio is 0.88

PB Ratio Sector Rank

40.18%
AVNS price to book ratio is higher than 40.18% of companies in Healthcare sector

PS Ratio

PS Ratio

1.06
AVNS price to sales ratio is 1.06

PS Ratio Sector Rank

26.47%
AVNS price to sales ratio is higher than 26.47% of companies in Healthcare sector

Enterprise value

Enterprise Value

$793.03 M
AVNS enterprise value is $793.03 million

Enterprise Value Sector Rank

72.67%
AVNS enterprise value is higher than 72.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.29
AVNS EV/EBITDA is -2.29

EV/EBITDA Sector Rank

33.04%
AVNS EV/EBITDA is higher than 33.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.37
AVNS annual current ratio is 2.37

Annual Quick Ratio

1.53
AVNS annual quick ratio is 1.53

Leverage

Annual Debt To Equity

0.16
AVNS annual debt to equity ratio is 0.16

Annual Interest Coverage Ratio

-32.06
AVNS annual interest coverage ratio is -32.06

Risk & Stability

Piotroski F-Score

6
AVNS piotroski f-score is 6

Altman Z-Score

0.20
AVNS altman z-score is 0.20

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.15 B
AVNS annual total assets is $1.15 billion

Annual Non Current Assets

$760.80 M
AVNS annual long term assets is $760.80 million

Annual Current Assets

$393.40 M
AVNS annual total current assets is $393.40 million

Annual Cash & Cash Equivalents

$107.70 M
AVNS annual cash & cash equivalents is $107.70 million

Equity

Annual Book Value

$828.50 M
AVNS annual book value is $828.50 million

Annual Working Capital

$227.50 M
AVNS annual working capital is $227.50 million

Liabilities

Annual Total Liabilities

$325.70 M
AVNS annual total liabilities is $325.70 million

Annual Total Long Term Liabilities

$159.80 M
AVNS annual total long term liabilities is $159.80 million

Annual Current Liabilities

$165.90 M
AVNS annual total current liabilities is $165.90 million

Annual Accounts Payable

$54.30 M
AVNS annual accounts payable is $54.30 million

Debt

Annual Total Debt

$170.20 M
AVNS annual total debt is $170.20 million

Annual Total Debt 1-Year Change

-18.6%
AVNS annual total debt is down -18.6% year-on-year

Annual Long Term Debt

$149.90 M
AVNS annual long term debt is $149.90 million

Annual Short Term Debt

$20.30 M
AVNS annual short term debt is $20.30 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$647.30 M
AVNS annual total expenses is $647.30 million

Annual Operating Expenses

$340.80 M
AVNS annual total operating expenses is $340.80 million

Annual Cost Of Goods Sold

$306.50 M
AVNS annual cost of goods sold is $306.50 million

Annual SGA

$318.50 M
AVNS annual SGA is $318.50 million

Annual D&A

$45.50 M
AVNS annual depreciation & amortization is $45.50 million

Annual Interest Expense

$12.20 M
AVNS annual interest expense is $12.20 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$100.70 M
AVNS annual cash flow from operations is $100.70 million

Annual CFO 1-Year Change

+210.8%
AVNS annual cash flow from operations is up +210.8% year-on-year

Annual CFI

-$27.50 M
AVNS annual cash flow from investing activities is -$27.50 million

Annual CFI 1-Year Change

-227.31%
AVNS annual cash flow from investing activities is down -227.31% year-on-year

Annual CFF

-$49.10 M
AVNS annual cash flow from financing activities is -$49.10 million

Annual CFF 1-Year Change

+47.88%
AVNS annual cash flow from financing activities is up +47.88% year-on-year

Free CashFlow

Annual FCF

$82.90 M
AVNS annual free cash flow is $82.90 million

Annual FCF 1-Year Change

+467.81%
AVNS annual free cash flow is up +467.81% year-on-year

CAPEX

Annual CAPEX

$17.80 M
AVNS annual capital expenditures is $17.80 million

Annual CAPEX 1-Year Change

0%
AVNS {parameterFullLabel} has remained unchanged year-on-year

Institutional Ownership

Similar stocks

AVDL logo
Avadel Pharmaceuticals (AVDL)
AVBP logo
ArriVent BioPharma (AVBP)
OMI logo
Owens & Minor (OMI)
ORGO logo
Organogenesis Holdings (ORGO)
BCYC logo
Bicycle Therapeutics (BCYC)
SIBN logo
SI-BONE (SIBN)
OPT logo
Opthea Limited (OPT)
EMBC logo
Embecta (EMBC)
AVXL logo
Anavex Life Sciences (AVXL)

FAQ

  • What is the ticker symbol for Avanos Medical?
  • Does Avanos Medical pay dividends?
  • What sector is Avanos Medical in?
  • What industry is Avanos Medical in?
  • What country is Avanos Medical based in?
  • When did Avanos Medical go public?
  • Is Avanos Medical in the S&P 500?
  • Is Avanos Medical in the NASDAQ 100?
  • Is Avanos Medical in the Dow Jones?
  • When was Avanos Medical's last earnings report?
  • When does Avanos Medical report earnings?
  • Should I buy Avanos Medical stock now?

What is the ticker symbol for Avanos Medical?

The ticker symbol for Avanos Medical is NYSE:AVNS

Does Avanos Medical pay dividends?

No, Avanos Medical does not pay dividends

What sector is Avanos Medical in?

Avanos Medical is in the Healthcare sector

What industry is Avanos Medical in?

Avanos Medical is in the Medical Devices industry

What country is Avanos Medical based in?

Avanos Medical is headquartered in United States

When did Avanos Medical go public?

Avanos Medical's initial public offering (IPO) was on October 21, 2014

Is Avanos Medical in the S&P 500?

No, Avanos Medical is not included in the S&P 500 index

Is Avanos Medical in the NASDAQ 100?

No, Avanos Medical is not included in the NASDAQ 100 index

Is Avanos Medical in the Dow Jones?

No, Avanos Medical is not included in the Dow Jones index

When was Avanos Medical's last earnings report?

Avanos Medical's most recent earnings report was on Feb 26, 2025

When does Avanos Medical report earnings?

The next expected earnings date for Avanos Medical is May 2, 2025

Should I buy Avanos Medical stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions